New hope for rare brain disease: platform trial launches
Disease control
Not yet recruiting
This study tests several experimental treatments for progressive supranuclear palsy (PSP), a rare brain disease that affects movement and thinking. About 440 people with early-stage PSP will join this platform trial to see if any of the treatments can slow the disease. The goal i…
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated May 17, 2026 10:39 UTC